QA: Kura Oncology Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2023_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc

  xvar xval
0 AssetsCurrent 446,426,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,540,000
3 remainder_Assets 7,340,000
4 LiabilitiesCurrent 24,057,000
5 LiabilitiesNoncurrent 11,971,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 47,665,637
9 ResearchAndDevelopmentExpense 97,402,412
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,486,402
13 remainder_ComprehensiveNetIncome -28,262,153
  yvar yval
0 Assets 456,306,000
1 Liabilities 36,028,000
2 Expenses 145,068,049
3 Revenues 0
4 StockholdersEquity 420,278,000
5 NetIncome -141,581,647
6 ComprehensiveNetIncome -155,712,724
7 BaseVar 334,575,302
8 EconomicCapitalRatiobeforeLimitedLiability 3.09
9 EconomicCapitalRatio 3.75

Edgar->Model Mapping

Feature Distribution

Change over Time